The prevalence of up-to-date lung cancer screening among eligible individuals increased 6% between 2022 and 2024, according to a study published April 27 in JAMA Internal Medicine.
For the study, researchers from Lexington-based University of Kentucky analyzed Behavioral Risk Factor Surveillance System data to identify lung cancer screening trends between 2022 and 2024.
Here are five notes from the study:
- The study analyzed screening rates among 26,104 individuals who were between 50 and 80 years old, currently a smoker or had quit within 15 years, and had a history of smoking 20 or more pack-years.
- Of those individuals, 24.49% were up to date on their lung cancer screenings in 2024.
Screening prevalence increased with age, with 11.32% of individuals ages 50-54 up to date on their screening compared to 31.2% of those ages 75-79. - Individuals with military-related insurance coverage, Medicare or Medicaid were more likely to be up to date with lung cancer screening, while individuals without insurance were less likely to be up to date.
- While no declines were reported, there was little to no change in screening rates between 2022 and 2024 among uninsured, Hispanic, non-Hispanic Asian and non-Hispanic Black individuals or individuals ages 75-79.
- Between 2022 and 2024, there were significant screening increases across 21 states.
Massachusetts had the highest up-to-date lung cancer screen prevalence at 38.36%, while South Dakota had the lowest at 13.43%.
Read the full study here.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
